QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,086 signal articles · 532 in last 24h · 103,714 total before filter · latest 23m ago
532last 24h
2516last 7d
482● bullish (7d)
255● bearish (7d)
197publishers
AllMacro238Earnings1482M&A142Regulatory15Product5Analyst29
✕ clear all filtersticker: GENBsentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating
Insider Monkey107d agobullish
H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C. Wainwright initiated coverage of Generate Biomedicines, Inc. (NASDAQ:GENB) with a Buy rating, setting a $16 price target. The firm told investors in a research note that the stock has fallen over 20% even as GB-0895 advanced into […]

GENB